Stem cell transplant in India costs a fraction of what it does abroad but the country has very few centres where the procedure can be done and not enough dedicated medical staff, says an expert.
A stem cell transplant can cost up to Rs.1 crore (approx $223,000) abroad, depending on the type of procedure, and the patient is asked to deposit the full amount before the transplant, Kumar told IANS.
In comparison, in India it costs Rs.10-20 lakh in private hospitals, while in government hospitals it is much cheaper – Rs.3-6 lakh – depending on the type of procedure, he said.
According to Kumar, stem cell transplant has shown 50 percent success in treating certain kinds of cancers and even more in other major conditions like beta thalassemia, a genetic blood disorder, and aplastic anaemia, a condition where bone marrow does not produce sufficient new cells to replenish blood cells. Stem cell transplant has shown 70-80 percent success in treating non-malignant diseases like aplastic anaemia.
Stem cells can be taken from siblings or family members after tissue matching, known as allogeneic transplant, from the patient’s blood, known as autologous transplant or can be harvested from a newborn’s umbilical cord, which is a rich source of such cells.
Among the major hospitals that carry out stem cell transplant are AIIMS and the Army Hospital in the capital, the Tata Memorial Centre and Jaslok Hospital in Mumbai and CMC in Tamil Nadu’s Vellore town. There are more than 500 centres in the world where stem cell transplant is done, he said.
“Around 500 stem cell transplants are done in India in a year, which is very small compared to the need. We need many, many more centres in India,” Kumar said.
India also needs to set up more stem cell banks and a registry of donors, like in the West, with complete information such as blood group and tissue matching to make it easier for matching for a stem cell procedure, he said.
“A registry of donors is useful when a match can’t be found in the family of the patient for stem cell transplant.”
Besides setting up more stem cell transplant centres or setting aside an exclusive block in a hospital for the purpose, more trained doctors are needed as well as hospital staff, he feels.
“There should also be more awareness among physicians so that they refer the patients at the right time for a stem cell transplant,” he said.
Kumar said there is a better success rate in the case of thalassemia if the patient is referred by the treating doctor for a stem cell transplant early.
He added that more awareness should be spread about the procedure among the patient’s family and the community.
“There is a lack of awareness about stem cell transplant among people. Many people asked to donate stem cells, even among the patient’s own family, feel they will get weakened by donating. And this is also true among the educated.
“Stem cell donation is just like blood donation,” Kumar said.
AIIMS has its stem cell transplant wing on the seventh floor of the cancer department. There are nine beds, and they are generally full, the doctor said.
The hospital does about five procedures in a month. For a procedure called allogeneic, where a genetically similar donor’s tissue is used, like a sibling or even an unrelated donor, great care has to be taken before and after the procedure.
In some cases, despite matching with the donor, the patient can reject the graft. Then it involves a long process of giving immunosuppressants, or medications that help prevent organ rejection in transplants and reduce inflammation, or steroids to help the patient in accepting the transplant, he said.